ZA966801B - Antigenic preparations - Google Patents

Antigenic preparations

Info

Publication number
ZA966801B
ZA966801B ZA966801A ZA966801A ZA966801B ZA 966801 B ZA966801 B ZA 966801B ZA 966801 A ZA966801 A ZA 966801A ZA 966801 A ZA966801 A ZA 966801A ZA 966801 B ZA966801 B ZA 966801B
Authority
ZA
South Africa
Prior art keywords
antigenic preparations
antigenic
preparations
Prior art date
Application number
ZA966801A
Other languages
English (en)
Inventor
Dieter Farnow
Joachim Karle
Igor D Poliakov
Ludmilla G Ivanova
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of ZA966801B publication Critical patent/ZA966801B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/165—Yeast isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/72—Candida
    • C12R2001/725—Candida albicans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/921—Candida
    • Y10S435/922—Candida albicans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA966801A 1995-08-11 1996-08-12 Antigenic preparations ZA966801B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9516461A GB2304347A (en) 1995-08-11 1995-08-11 Antigenic preparations

Publications (1)

Publication Number Publication Date
ZA966801B true ZA966801B (en) 1997-03-14

Family

ID=10779086

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA966801A ZA966801B (en) 1995-08-11 1996-08-12 Antigenic preparations

Country Status (25)

Country Link
US (2) US6379678B1 (es)
EP (1) EP0863991B1 (es)
JP (3) JP4285768B2 (es)
KR (1) KR100447926B1 (es)
CN (1) CN1228450C (es)
AR (1) AR008982A1 (es)
AT (1) ATE253641T1 (es)
AU (1) AU717731B2 (es)
CA (1) CA2229203C (es)
CO (1) CO4750671A1 (es)
CZ (1) CZ294394B6 (es)
DE (1) DE69630611T2 (es)
DK (1) DK0863991T3 (es)
ES (1) ES2206588T3 (es)
GB (1) GB2304347A (es)
HU (1) HU224223B1 (es)
IL (1) IL123153A (es)
MX (1) MX9801180A (es)
NZ (1) NZ316062A (es)
PL (1) PL186523B1 (es)
PT (1) PT863991E (es)
RU (1) RU2245721C2 (es)
SK (1) SK282746B6 (es)
WO (1) WO1997007232A1 (es)
ZA (1) ZA966801B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
GB2304347A (en) * 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
EP0834322A3 (en) * 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Mycosis vaccine
WO1999049876A2 (en) * 1998-03-31 1999-10-07 Abbott Laboratories Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof
CA2325063A1 (en) * 2000-10-27 2002-04-27 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of National Defence Method for detecting antibodies to and antigens of fungal and yeast exposures
ES2676503T3 (es) * 2002-12-16 2018-07-20 Globeimmune, Inc. Vacunas basadas en levadura como inmunoterapia
US9820986B2 (en) * 2005-03-04 2017-11-21 Taiwan Hopaz Chems, Mfg. Co., Ltd. Glycopeptide compositions
WO2010032139A1 (en) * 2008-09-17 2010-03-25 Hunter Immunology Limited Bacterial and fungal vaccines for the treatment of asthma
RU2660365C1 (ru) * 2015-11-20 2018-07-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова) Способ получения специфических антигенных препаратов из клинически значимых дрожжевых грибов
HUE054207T2 (hu) 2016-03-15 2021-08-30 Igor Polyakov Új immunbiológiai termékek
ES2894370T3 (es) * 2016-03-15 2022-02-14 Igor Polyakov Composiciones para el tratamiento y prevención de enfermedades podales y de las pezuñas

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867555A (en) * 1972-11-29 1975-02-18 Anheuser Busch Manufacture of yeast protein isolate having a reduced nucleic acid content by an alkali process
FR2338287A1 (fr) * 1976-01-19 1977-08-12 Idemitsu Kosan Co Polysaccharide ayant la propriete de former un gel et procede microbiologique pour sa preparation
JPS536413A (en) * 1976-07-07 1978-01-20 Kureha Chem Ind Co Ltd Preparation of n-containing polysaccharides
NO153458C (no) * 1978-06-07 1986-03-26 Inst Experimentalnoi Veterinar Fremgangsm¨te for fremstilling av vaksine for profylakse o g behandling av ringorm hos pelsdyr og kaniner for¨rsaket av trichophyton mentagrophytes.
AU547928B2 (en) * 1981-11-03 1985-11-14 Sutka, K. Antigenic preparation from candida guilliermondii
GB8506373D0 (en) * 1985-03-12 1985-04-11 Axon Healthcare Ltd Antigens antibodies
GB8913737D0 (en) 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
WO1991015878A1 (de) 1990-04-09 1991-10-17 Adalbert Kopera Antennenanordnung
US5277904A (en) * 1990-10-26 1994-01-11 Pier Allan C Broad spectrum dermatophyte vaccine
RU2020959C1 (ru) 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
WO1995005400A1 (en) 1993-08-19 1995-02-23 Minnesota Mining And Manufacturing Company Heparin functional affinity supports
AUPM473294A0 (en) * 1994-03-25 1994-04-21 Franklyn, Kathleen Mary Peptides for diagnostics and therapeutics
GB2304347A (en) 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
EP0834322A3 (en) 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Mycosis vaccine

Also Published As

Publication number Publication date
ATE253641T1 (de) 2003-11-15
CA2229203A1 (en) 1997-02-27
HUP9802419A2 (hu) 1999-02-01
US20040071737A1 (en) 2004-04-15
DE69630611T2 (de) 2004-06-03
NZ316062A (en) 1998-12-23
GB9516461D0 (en) 1995-10-11
JP2008245658A (ja) 2008-10-16
DE69630611D1 (de) 2003-12-11
IL123153A0 (en) 1998-09-24
HUP9802419A3 (en) 1999-12-28
JP4285768B2 (ja) 2009-06-24
HU224223B1 (hu) 2005-06-28
KR100447926B1 (ko) 2004-11-09
EP0863991B1 (en) 2003-11-05
PL324975A1 (en) 1998-06-22
DK0863991T3 (da) 2004-02-09
CO4750671A1 (es) 1999-03-31
PT863991E (pt) 2004-01-30
PL186523B1 (pl) 2004-01-30
AR008982A1 (es) 2000-03-08
AU717731B2 (en) 2000-03-30
JP4286311B2 (ja) 2009-06-24
KR19990036326A (ko) 1999-05-25
CN1199426A (zh) 1998-11-18
GB2304347A (en) 1997-03-19
SK17798A3 (en) 1998-07-08
RU2245721C2 (ru) 2005-02-10
US6379678B1 (en) 2002-04-30
JP2008266352A (ja) 2008-11-06
WO1997007232A1 (en) 1997-02-27
EP0863991A1 (en) 1998-09-16
SK282746B6 (sk) 2002-12-03
US7090857B2 (en) 2006-08-15
CA2229203C (en) 2011-12-13
CZ40098A3 (cs) 1998-07-15
JP4286312B2 (ja) 2009-06-24
IL123153A (en) 2002-05-23
AU6820796A (en) 1997-03-12
JPH11511019A (ja) 1999-09-28
MX9801180A (es) 1998-04-30
CN1228450C (zh) 2005-11-23
ES2206588T3 (es) 2004-05-16
CZ294394B6 (cs) 2004-12-15

Similar Documents

Publication Publication Date Title
GB9513261D0 (en) Vaccines
IL139235A0 (en) Pharmaceutical preparations
CZ197595A3 (en) Vaccine preparations
GB9503240D0 (en) Preparation
PL328001A1 (en) Injectable quinolonic preparations
PL321686A1 (en) Trensdermal preparation
ZA966801B (en) Antigenic preparations
GB2331521B (en) Vaccine preparations
GB9526613D0 (en) Sequence
IL115197A0 (en) Vaccine preparations
GB9526433D0 (en) Vaccine component
AU7623296A (en) Microcellulose-based preparations
PL311552A1 (en) Cosmetic preparations
GB9419969D0 (en) Vaccine
GB9513260D0 (en) Vaccines
GB9518946D0 (en) Vaccines
ZA964644B (en) Vaccines
ZA962612B (en) Vaccines
ZA962036B (en) Vaccines
GB9525657D0 (en) Vaccines
GB9524825D0 (en) Vaccines
GB9512827D0 (en) Vaccines
GB9517269D0 (en) Vaccines
GB9514088D0 (en) Vaccines
GB9513107D0 (en) Vaccines